![](/img/cover-not-exists.png)
Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508-2515
Schernthaner, G., Gross, J., Rosenstock, J., Guarisco, M., Fu, M., Yee, J., Kawaguchi, M., Canovatchel, W., Meininger, G.Volume:
36
Journal:
Diabetes Care
DOI:
10.2337/dc13-er12a
Date:
December, 2013
File:
PDF, 446 KB
2013